Key result
Heart transplantation for electrical storm yields comparable 1-year survival to standard indications.
Why the study?
Urgent heart transplantation may be the only curative option for refractory electrical storm, and although France provides an expert-reviewed allocation exception for life-threatening ventricular arrhythmias, contemporary data on these high-urgency patients remain scarce.
Does urgent heart transplantation for electrical storm yield comparable one-year all-cause mortality compared to standard heart transplantation indications in adult recipients?
Cohort (n=2,891)
Yes
Does urgent heart transplantation for electrical storm yield comparable one-year all-cause mortality compared to standard heart transplantation indications in adult recipients?
Heart transplantation for refractory electrical storm is feasible and achieves 1-year and 5-year survival rates comparable to standard transplant indications, supporting its role as a bailout therapy when medical therapy and ablation fail.
Answers are grounded in this paper and cite their sources.
Supports urgent HTx as bailout for refractory electrical storm; leaves open need for prospective validation before broader adoption.
Background Electrical storm (ES) is a severe arrhythmic emergency associated with high short-term mortality. When unresponsive to medical therapy, ablation, or support devices, urgent heart transplantation (HTx) may be the only curative option. In France, an expert-reviewed transplantation allocation exists for refractory ventricular ablation (VA), but contemporary data on these high-urgency patients remain scarce. Methods We performed a retrospective analysis of prospectively collected registry data, including all adult HTx in France between 2018 and 2025 across 21 centers. Patients transplanted under the "life-threatening VA" exception were classified as the ES-HTx group. Baseline characteristics, acute arrhythmia management, and outcomes were analyzed. The primary endpoint was one-year all-cause mortality after propensity score matching; secondary endpoints were five-year survival, ablation trends, and determinants of post-HTx prognosis using univariate Cox. Results Among 2,891 HTx recipients, 141 (4.9%) were transplanted for ES. Compared with standard HTx, ES-HTx patients were older (median 57 vs 52 years), predominantly male (85%), and presented with higher LVEF (25% vs 20%) but less systemic congestion. The index arrhythmia was most often monomorphic VT (50%), with nearly all patients receiving amiodarone (84%) and adjunctive β-blockers (64%) or lidocaine (42%). Acute ablation was attempted in 29%, with rates rising steadily during the study period. Advanced supports were used including inotropes (20%) and ECLS (9%). At 12 months, survival was 75.2% in ES-HTx versus 79.3% in standard HTx (HR 1.04, 95% CI 0.68-1.60; p = 0.84). Outcomes remained similar at 5 years (72.0% vs 69.1%). Mortality was predominantly early and driven by infection and multiorgan failure. In univariate analysis, classical predictors of mortality (bilirubin, creatinine, BMI) remained significant, whereas arrhythmic features and etiology did not independently affect prognosis. Conclusion HTx for ES is feasible and yields survival comparable to standard indications, supporting its role as a legitimate therapeutic option when other therapeutic options are not feasible or have failed. Ablation remains underutilized before HTx but is increasingly performed, reflecting evolving practice. Early referral and timely escalation are essential to bridge patients to transplantation, while prospective studies are needed to refine candidate selection and optimize integration of adjunctive therapiesMain Figure
No takes yet. Share an insight, caveat, or question.
Rakza et al. (2026) conducted a cohort in Electrical storm and refractory ventricular arrhythmia requiring heart transplantation (n=2,891). Heart transplantation for electrical storm / refractory ventricular arrhythmia vs. Standard indication heart transplantation was evaluated on One-year all-cause mortality (reported as 12-month survival) (HR 1.04, 95% CI 0.68-1.60, p=0.84). Heart transplantation for electrical storm yielded comparable 12-month survival to standard indications.
Synapse has enriched 10 related papers. Consider them for comparative context: